Post-market Review of Ezetimibe – Targeted Stakeholder Forum

Page last updated: 27 January 2017

At the request of the Reference Group of the Post-market Review of Ezetimibe, a targeted Stakeholder Forum was held in Canberra on Friday 11 November 2016. The Forum sought additional stakeholder input to further inform the Review. It was specifically targeted to pharmaceutical sponsors who either have a current Pharmaceutical Benefit Scheme medicine listing for ezetimibe or in combination with ezetimibe, or propose to have one in the near future. 

The Outcome Statement was sent to all attending Stakeholders for comment on 23 November 2016. To view the Outcome Statement and Stakeholder comments please go to the Post-market Review of Ezetimibe page.